SSGJ-608 |
608; SSGJ-608 |
Phase 3 Clinical |
Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Spondylarthritis; Psoriasis; Plaque psoriasis |
Details
|
QX002N |
QX-002N |
Phase 3 Clinical |
Qyuns Therapeutics Co Ltd |
Spondylitis, Ankylosing; Asthma |
Details
|
Roconkibart |
JS005 |
Phase 3 Clinical |
Shanghai Junshi Biosciences Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylarthritis; Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
Gumokimab |
AK-111 |
Phase 3 Clinical |
Zhongshan Akeso Biopharma Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylarthritis; Spondylitis, Ankylosing; Skin Diseases; Psoriasis; Plaque psoriasis |
Details
|
Izokibep |
IMG-020; IMG020; ABY-035; AFB-035 |
Phase 3 Clinical |
Affibody Ab |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis |
Details
|
Recombinant human IL-17A/F humanized antibody (Livzon Pharmaceutical Group) |
LZM-012; LZM012; XKH004; XKH-004 |
Phase 3 Clinical |
Beijing Kanova Biomedical Technology Co Ltd, Livzon Pharmaceutical Group Inc |
Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
Secukinumab biosimilar (Bio-Thera Solutions) |
BAT-2306 |
Phase 3 Clinical |
Bio-Thera Solutions Ltd |
Autoimmune Diseases; Psoriasis; Plaque psoriasis |
Details
|
DMT-310 |
DMT-310 |
Phase 3 Clinical |
Dermata |
Acne Vulgaris; Rosacea |
Details
|
CJM-112 |
CJM-112 |
Phase 2 Clinical |
Novartis Pharma Ag |
Acne Vulgaris; Triple Negative Breast Neoplasms; Multiple Sclerosis; Multiple Myeloma; Psoriasis; Asthma; Colorectal Neoplasms; Hidradenitis Suppurativa; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
Sonelokimab |
M-1095; ALX-0761; MSB-0010841 |
Phase 2 Clinical |
Ablynx Nv |
Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa |
Details
|
SIM-0335 |
SIM-0335; SIM-335 |
Phase 2 Clinical |
BCY Pharm Co Ltd |
Plaque psoriasis |
Details
|
SCT-650C |
SCT650C; SCT-650-C; SCT-650C |
Phase 2 Clinical |
SinoCelltech Ltd |
Non-radiographic axial spondyloarthritis; Autoimmune Diseases; Plaque psoriasis |
Details
|
Isomyosamine |
MYMD-1 |
Phase 2 Clinical |
Mymd Pharmaceuticals Inc |
Depression; Anxiety; Hashimoto Disease; Frailty; Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Healthy Aging; Inflammation; Sarcopenia |
Details
|
CNTO-6785 |
CNTO-6785; FTC-001 |
Phase 1 Clinical |
Morphosys Ag, Johnson & Johnson Innovative Medicine |
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Pulmonary Disease, Chronic Obstructive |
Details
|
JNJ-61178104 |
JNJ-61178104 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine |
Autoimmune Diseases |
Details
|
Secukinumab biosimilar (BioRay Pharmaceutical) |
BR-201 |
Phase 1 Clinical |
BioRay Pharmaceutical Co Ltd |
Autoimmune Diseases; Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
JNJ-63823539 |
JNJ-63823539 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine |
Arthritis, Rheumatoid |
Details
|
Secukinumab Biosimilar(Celltrion) |
CT-P55 |
Phase 1 Clinical |
Celltrion Inc |
Plaque psoriasis |
Details
|
Secukinumab biosimilar (CSPC Pharmaceutical Group) |
SYS6012; SYS-6012 |
Phase 1 Clinical |
CSPC Pharmaceutical Group Ltd |
Plaque psoriasis |
Details
|
Secukinumab biosimilar (Gan & Lee) |
GLR1023; GLR-1023 |
Phase 1 Clinical |
Gan & Lee Pharmaceuticals |
Plaque psoriasis |
Details
|
anti-IL-17A humanized monoclonal antibody(Fontacea ) |
|
Phase 1 Clinical |
Shandong Fangtansi Biopharmaceutical Co Ltd |
Plaque psoriasis |
Details
|
CMAB-015 |
CMAB015; CMAB-015 |
Phase 1 Clinical |
Taizhou Mabtech Pharmaceutical Co Ltd |
Spondylitis, Ankylosing; Plaque psoriasis |
Details
|
DC-853 |
DC-853 |
Phase 1 Clinical |
Dice Therapeutics Inc |
Immune System Diseases |
Details
|
LEO-153339 |
LEO-153339 |
Phase 1 Clinical |
Leo Pharma Inc |
|
Details
|
HY-1770 |
HY1770; HT-17; HT17; HY-1770 |
Phase 1 Clinical |
Suzhou Pharmavan Co Ltd |
Dermatitis, Atopic; Plaque psoriasis |
Details
|
ZL-1102 |
ZL-1102; CB-001 |
Phase 1 Clinical |
Crescendo Biologics Ltd, Zai Lab (Shanghai) Co Ltd |
Psoriasis |
Details
|
UCB-0159 |
UCB-0159 |
Phase 1 Clinical |
Ucb Sa |
Autoimmune Diseases |
Details
|
SSGJ-608 |
608; SSGJ-608 |
Phase 3 Clinical |
Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Spondylarthritis; Psoriasis; Plaque psoriasis |
Details
|
QX002N |
QX-002N |
Phase 3 Clinical |
Qyuns Therapeutics Co Ltd |
Spondylitis, Ankylosing; Asthma |
Details
|
Roconkibart |
JS005 |
Phase 3 Clinical |
Shanghai Junshi Biosciences Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylarthritis; Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
Gumokimab |
AK-111 |
Phase 3 Clinical |
Zhongshan Akeso Biopharma Co Ltd |
Non-radiographic axial spondyloarthritis; Spondylarthritis; Spondylitis, Ankylosing; Skin Diseases; Psoriasis; Plaque psoriasis |
Details
|
Izokibep |
IMG-020; IMG020; ABY-035; AFB-035 |
Phase 3 Clinical |
Affibody Ab |
Non-radiographic axial spondyloarthritis; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis |
Details
|
Recombinant human IL-17A/F humanized antibody (Livzon Pharmaceutical Group) |
LZM-012; LZM012; XKH004; XKH-004 |
Phase 3 Clinical |
Beijing Kanova Biomedical Technology Co Ltd, Livzon Pharmaceutical Group Inc |
Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
Secukinumab biosimilar (Bio-Thera Solutions) |
BAT-2306 |
Phase 3 Clinical |
Bio-Thera Solutions Ltd |
Autoimmune Diseases; Psoriasis; Plaque psoriasis |
Details
|
DMT-310 |
DMT-310 |
Phase 3 Clinical |
Dermata |
Acne Vulgaris; Rosacea |
Details
|
CJM-112 |
CJM-112 |
Phase 2 Clinical |
Novartis Pharma Ag |
Acne Vulgaris; Triple Negative Breast Neoplasms; Multiple Sclerosis; Multiple Myeloma; Psoriasis; Asthma; Colorectal Neoplasms; Hidradenitis Suppurativa; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
Sonelokimab |
M-1095; ALX-0761; MSB-0010841 |
Phase 2 Clinical |
Ablynx Nv |
Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa |
Details
|
SIM-0335 |
SIM-0335; SIM-335 |
Phase 2 Clinical |
BCY Pharm Co Ltd |
Plaque psoriasis |
Details
|
SCT-650C |
SCT650C; SCT-650-C; SCT-650C |
Phase 2 Clinical |
SinoCelltech Ltd |
Non-radiographic axial spondyloarthritis; Autoimmune Diseases; Plaque psoriasis |
Details
|
Isomyosamine |
MYMD-1 |
Phase 2 Clinical |
Mymd Pharmaceuticals Inc |
Depression; Anxiety; Hashimoto Disease; Frailty; Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Healthy Aging; Inflammation; Sarcopenia |
Details
|
CNTO-6785 |
CNTO-6785; FTC-001 |
Phase 1 Clinical |
Morphosys Ag, Johnson & Johnson Innovative Medicine |
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Pulmonary Disease, Chronic Obstructive |
Details
|
JNJ-61178104 |
JNJ-61178104 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine |
Autoimmune Diseases |
Details
|
Secukinumab biosimilar (BioRay Pharmaceutical) |
BR-201 |
Phase 1 Clinical |
BioRay Pharmaceutical Co Ltd |
Autoimmune Diseases; Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis |
Details
|
JNJ-63823539 |
JNJ-63823539 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine |
Arthritis, Rheumatoid |
Details
|
Secukinumab Biosimilar(Celltrion) |
CT-P55 |
Phase 1 Clinical |
Celltrion Inc |
Plaque psoriasis |
Details
|
Secukinumab biosimilar (CSPC Pharmaceutical Group) |
SYS6012; SYS-6012 |
Phase 1 Clinical |
CSPC Pharmaceutical Group Ltd |
Plaque psoriasis |
Details
|
Secukinumab biosimilar (Gan & Lee) |
GLR1023; GLR-1023 |
Phase 1 Clinical |
Gan & Lee Pharmaceuticals |
Plaque psoriasis |
Details
|
anti-IL-17A humanized monoclonal antibody(Fontacea ) |
|
Phase 1 Clinical |
Shandong Fangtansi Biopharmaceutical Co Ltd |
Plaque psoriasis |
Details
|
CMAB-015 |
CMAB015; CMAB-015 |
Phase 1 Clinical |
Taizhou Mabtech Pharmaceutical Co Ltd |
Spondylitis, Ankylosing; Plaque psoriasis |
Details
|
DC-853 |
DC-853 |
Phase 1 Clinical |
Dice Therapeutics Inc |
Immune System Diseases |
Details
|
LEO-153339 |
LEO-153339 |
Phase 1 Clinical |
Leo Pharma Inc |
|
Details
|
HY-1770 |
HY1770; HT-17; HT17; HY-1770 |
Phase 1 Clinical |
Suzhou Pharmavan Co Ltd |
Dermatitis, Atopic; Plaque psoriasis |
Details
|
ZL-1102 |
ZL-1102; CB-001 |
Phase 1 Clinical |
Crescendo Biologics Ltd, Zai Lab (Shanghai) Co Ltd |
Psoriasis |
Details
|
UCB-0159 |
UCB-0159 |
Phase 1 Clinical |
Ucb Sa |
Autoimmune Diseases |
Details
|